S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
US Dollar Replaced By "Biden Bucks"? (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Wall Street slips as weak earnings hit tech, travel stocks
US Dollar Replaced By "Biden Bucks"? (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
US Dollar Replaced By "Biden Bucks"? (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Wall Street slips as weak earnings hit tech, travel stocks
US Dollar Replaced By "Biden Bucks"? (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
US Dollar Replaced By "Biden Bucks"? (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Wall Street slips as weak earnings hit tech, travel stocks
US Dollar Replaced By "Biden Bucks"? (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
US Dollar Replaced By "Biden Bucks"? (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Wall Street slips as weak earnings hit tech, travel stocks
US Dollar Replaced By "Biden Bucks"? (Ad)
NASDAQ:VERA

Vera Therapeutics - VERA Insider Trading & Ownership

$17.95
-0.04 (-0.22%)
(As of 08/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$16.27
$18.30
50-Day Range
$12.82
$18.32
52-Week Range
$12.28
$37.11
Volume
88,255 shs
Average Volume
93,701 shs
Market Capitalization
$485.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$34.00

Vera Therapeutics (NASDAQ:VERA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
43.10%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$9.07 M
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$594,865.51

VERA Insider Buying and Selling by Quarter

Get VERA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Vera Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Vera Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/3/2022Joanne CurleyInsiderSell988$16.81$16,608.2817,285  
7/19/2022Joanne CurleyInsiderSell11,444$16.01$183,218.4418,273  
7/14/2022Joanne CurleyInsiderSell9,104$15.14$137,834.5618,273  
7/7/2022Joanne CurleyInsiderSell9,666$15.05$145,473.3021,023  
6/22/2022Joanne CurleyInsiderSell1,545$15.01$23,190.4523,688  
6/17/2022Joanne CurleyInsiderSell5,887$15.04$88,540.4823,994  
6/15/2022Sean GrantCFOBuy5,000$13.60$68,000.002,816  
2/10/2022Patrick G EnrightDirectorBuy333,333$15.00$4,999,995.00  
2/10/2022Sofinnova Venture Partners X,Major ShareholderBuy266,666$15.00$3,999,990.00  
5/18/2021Llp AbingworthMajor ShareholderBuy772,727$11.00$8,499,997.00
(Data available from 1/1/2013 forward)












VERA Insider Trading Activity - Frequently Asked Questions

Who is on Vera Therapeutics's Insider Roster?

The list of insiders at Vera Therapeutics includes Joanne Curley, Llp Abingworth, Patrick G Enright, Sean Grant, and Sofinnova Venture Partners X,. Learn more on insiders at VERA.

What percentage of Vera Therapeutics stock is owned by insiders?

43.10% of Vera Therapeutics stock is owned by insiders. Learn more on VERA's insider holdings.

Which Vera Therapeutics insiders have been buying company stock?

The following insiders have purchased VERA shares in the last 24 months: Llp Abingworth ($8,499,997.00), Patrick G Enright ($4,999,995.00), Sean Grant ($68,000.00), and Sofinnova Venture Partners X, ($3,999,990.00).

How much insider buying is happening at Vera Therapeutics?

Insiders have purchased a total of 1,377,726 VERA shares in the last 24 months for a total of $17,567,982.00 bought.

Which Vera Therapeutics insiders have been selling company stock?

The following insider sold VERA shares in the last 24 months: Joanne Curley ($594,865.51).

How much insider selling is happening at Vera Therapeutics?

Insiders have sold a total of 38,634 Vera Therapeutics shares in the last 24 months for a total of $594,865.51 sold.

This page (NASDAQ:VERA) was last updated on 8/10/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.